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Impact of High infiation Pressures on Six-Month
Angiogrsphic Foiiow-up After Coronsry Stent
Piacement
J. Hausleiter,H. SchUhlen, S. Elezi, H. Walter, M. Hadamifzky,
J. Dirschinger, A. Schomig. Deutsches HerzzerstrunsA4iinchen,Germany, 1.
Medizinische Klinik, Technische University, Munich, Germany
The purpose of this retrospective analysis was to investigate the impact of
high (>15 atm) pressure stent dilatation (435 lesions) on acute and late an-
giographic outcome in comparison to lesions without high pressure dilatation
(622 lesions).
Control High pressure p-value
MLD me (mm) 0.73 k 0.43 0.66 + 0.43 0.004
%-etenosispri 76,3 k 13.7 78.7 + 13.4 0.006
Mesn preaaure(stm) 12.0 * 1.s 17.1 * 1,5
Balloor/veaael ratio 1,04* 0.13 1.10 + 0,13 <0,001
Acute gain (mm) 2.20 + 0.60 2.44 + 0.60 <0.001
MLD post (mm) 2.94 * 0.48 3.09 + 0.48 <0,001
“A-stenosispost 7,6 + 10.7 2.3 + 10.2 < 0.0+31
MLD 8-months(mm) 1.89 + 0.60 1.90 + 0,67 ns
O/~-stenosis6-months 39.1 + 23.3 38.0 k 24.8
Late lumen 10ss(mm) 1.05 + 0.80 1.19 + 0.80 :5005
Lossindex 0,49 & 0.38 0.50 * 0.34 ns
restenosisrate (“/0) 26.5 28.5 ns
Conclusions: The use of higher inflation pressures for stent placement
result in a significantly improved acute angiographic result. However, due to
a significantly higher late lumen loss, this benefit was not maintained at six
months. These data suggest that the technique of high pressure dilatations
might induce an increased neointimal proliferative response.
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El7825 High Pressure increases Late Loss After CoronaryStenting
F. FemAndez-Avi16s,J.J. Alonso, J.M. DurAn, F. Gimeno, E. Garcia-Moran,
J. Paniagua, 1.Garcimarth J.C. Muiioz. +fospital Universitario, Va//ado/id,
Spain
High pressure balloon dilation (HPD) associated with stent deployment nor-
malizes coronary lumen and reduces the risk of occlusion, but the impact of
this wall damaging strategy on restenotic process is still unknown.
To determine the influence of HPD on late loss, we analyzed the an-
giographic evolution of 225 lesions type A or B (ACC/AHA classification)
from 209 consecutive pts who underwent successful elective Palmaz-Schatz
coronaty stenting (CS). Non compliant or semi-compliant balloons were
used, mean maximal deployment pressure was 12.7 + 3.4 atm, and mean
belloon/attery ratio was 1.15 + 0.42. Angiographic follow-up was done at
6.9 + 1.2 months in 94% of eligible lesions. Multivariate analysis (multiple
regression) of 35 clinical, angiographic and procedural variables identified
two independent predictor of late loss: the post-CS minimal lumen diameter
(MLD) (B = 0.41, Cl 95%: 0.19-0.63, p < 0.01) and maximal deployment
pressure (B= 0.05, Cl 95%: 0.064-0.016, p -=0.001).
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Thus, HPD increases late loss after CS. Furlher studies are necessary to
determine optimal stent deployment pressure.
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m7826 The Optimsi Stent implantation Triai - Finai CoreLab Angiographic and Ultrasound Anaiysis
G.W. Stone, F.St. Gear, P.Fitzgerald, E. Alderman, P.Yock,
J.McB. Hodgson, T. Linnemeier. The Cardiovascular Institute, H Camino
Hospital, Mountain View, CA, USA
The optimal pressure for stent implantation, and the relationship between
implantation pressure and stent lumen dimensions have not been defined.
The necessity of IVUS guidance for optimal stenting is also controversial.
We therefore electively implanted 89 JJIS stents in 79 Ieaions in 76 patients.
Each stent was serially post dilated at 12, 15 and 18 atm. of pressure,
and examined by IVUS at each level. Independent core lab QCA and IVUS
analysis was performed. The results (mean values) appear in the Table
below:
t2 atm. 15 arm, 18 atm. P—
Measured balloondis. (mm) 3.30 3.38 3.48 0.00F
Meesured bsllocm-atieryratio 1.06 1.0s 1.13 0.0001
MLD (mm) (QCA) 2.78 2.S4 2.86 NS
MLD (mm) (IVUS) 2.72 2.91 3.04 0.0001
“/oDS (QCA) 10.60/0 9.1% S.5% NS
O/.DS (WUS) 6.2”/0 –0.4”/0 –4.7% 0.0001.,
Lumeriarea(mm2) (iVUS) 7.1 8.0 8.6 0.0001
The likelihood of the minimum etent area (MSA) meeting frequently used
IVUS criteria for optimal implantation appear below:
—
12 atm. 15 stm. 18 atm. P
MSA >90% mean ref area 28% 44% WA O.w.“ -
MSA >1OO”Aminref area 33% 50”h 60”/6 0.004
MSA >9.0 mm2 21% 37% 41% 0.003
MUSIC criteria 37% 61% 73% 0.0001
Cone/usiona: JJIS stent dimensions steadily increase as implantation
pressure is increased from 12 to 18 atm. Subtle measures of stent expan-
sion, readily apparent by IVUS, cannot be appreciated by QCA. However,
frequently used criteria of optimal stent implantation are often not achieved
despite 18 atm. of pressure and balloon to artery ratios of >1.1, the signifi-
cance of which deserves further study.
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m LsckofRenaiFunctionaiReeer’veinpatien*~ith
Mild Haert Failure
M.A.E. Rae, P.Magri, S. Cangianiello, L. DeNicola, R. Russo, V. Bellizzi,
B, MemoIi, M, VOIpSI. “Federico //” University Nap/ea, Italy, “LaSapienza”
University Roma, Italy
Theaimofthisstudy was to assess renal functional resewe (RFR) intheearly
or mild stages of heart failure. For this purpose, in 6 untreated patients (ege:
36+ 4 yrs) with idiopathic dilated cardiomyopathy and mild heart failure (HF)
(NYHA classes: I-11;ejection fra~ion: 39.0 + 2.1%) and in 8 sex-matched
healthy volunteers (N) (age: 39 + 4 yre), inulin and para-amino-hyppurate
sodium clearances were asaesssd during water diuresia in basal conditions
and during a 3-hour intravenous loading with standard aminoacid mixture.
Basal glomerular filtration rate (GFR) (mean: 95.1 * 4 ml/min) and renal
plasma flow (RPF) (mean: 405.5 +33 ml/min) were comparable in the two
groups. In N, GFR rose by 20.6 * 2% (p c 0.001) and RPF by 32.1 + 6% (p
< 0.001) during aminoacid load. In contrast, in HF both GFR and RPF were
unchanged by aminoacid load (+0.91 + 4% and –1.0 + 5%, respectively,
n.s.),These resultsdemonstrate that RFR isabaent in patients with mild hearl
failure and normal baseline renal function. This abnormality may contribute
to the precocious onset of sodium and water retention that has been recently
described in patients with mild HF, despite basal renal hemodynamics is
presetvad. In addition, since RFR has been indicated as a tool to investigate
the intrarenal balance between angiotensin II and nitric oxyde, our current
findings may reflect early abnormalities of this equilibrium in heart failure.
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m7832 Differentiei Reiease of the Cardiac Natriuretic
Peptides in Asymptomatic and Symptomatic Human
Heart Faiiure
C.-M. Wei, R.J. Rcdeheffer, L.J. McKinley, D.M. Heublein, J.C. Burnett, Jr..
Mayo Clinic, Rochester, MN, USA
Atrial (ANP), brain (BNP) and C-type natriuretic peptides (CNP) are struc-
turally homologous but genetically distinct cardiovascular peptides which
participate in cardiorenal homeostasis. While cardiac secretion of ANP and
BNP has been reported in severe human congestive heart failure (CHF), the
contribution of atrial and ventricular secretion of ANP and BNP as well as
